SeqOnce Biosciences is a Pasadena, CA-based life science company developing products for next-generation sequencing for the research and clinical markets. Its core product is a Library Construction kit featuring a single-tube, three-step, highly efficient protocol that includes fragmentation. The kit can be applied to DNA from any sample source and can be adapted to most sequencing applications. The company is led by co-founder and CSO Joseph Dunham, Ph.D., and CEO Chris Angermayer. SeqOnce completed a $1M seed financing to support commercialization of its library construction kit. The funds will be deployed to advance commercial availability and market adoption.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

May 2018